Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Neomorph, Inc

Clinical trials sponsored by Neomorph, Inc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for advanced kidney cancer: first human trial of NEO-811 begins Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New hope for advanced kidney cancer: first human trial of NEO-811 begins

Disease control Recruiting now

This early-stage study tests a new drug called NEO-811 in people with advanced clear cell kidney cancer that has spread or cannot be surgically removed. The goal is to find the safest dose and see how well the drug works. About 30 participants who have already tried other treatme…

Phase 1 • Sponsor: Neomorph, Inc • Aim: Disease control

Last updated Aug 05, 2026 00:00 UTC